🏅 FDA Orphan Designation

Gralise

gabapentin

Manufacturer: Golf Acquiror LLC

Indicated for:

NON RARE IN EUROPE: Post-herpetic neuralgiaOrphan

FDA-Approved Indications (1)

NON RARE IN EUROPE: Post-herpetic neuralgiaOrphan Designation

For the management of postherpetic neuralgia

Indications & Usage

1 INDICATIONS AND USAGE GRALISE is indicated for the management of postherpetic neuralgia. GRALISE is not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. GRALISE is indicated for the management of Postherpetic Neuralgia (PHN). Important Limitation: GRALISE is not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration (See Warnings and Precautions )

💙 Support Programs

View all →

GABAPENTIN

Pfizer

Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.